204 related articles for article (PubMed ID: 37580918)
1. Knowledge, attitude and practice towards pharmacovigilance and reporting of adverse drug reactions among health care professionals in Albania: A cross-sectional study.
Shkreli R; Dhamo K; Haloçi E; Tabaku A
Pak J Pharm Sci; 2023 May; 36(3):713-721. PubMed ID: 37580918
[TBL] [Abstract][Full Text] [Related]
2. Knowledge, attitudes and practice regarding pharmacovigilance and adverse drug reaction reporting among physicians and pharmacists in Egypt: a step toward personalized medicine implementation.
Aziz AA; Rogers S; Hassanien O; Shalaby L; Nagy M
Per Med; 2022 Nov; 19(6):495-507. PubMed ID: 36239598
[TBL] [Abstract][Full Text] [Related]
3. Exploring the factors and barriers of healthcare professionals in tertiary care hospitals toward pharmacovigilance: a multicenter study from Khyber Pakhtunkhwa, Pakistan.
Sharif MJH; Farrukh MJ; Khan FU; Khan Q; Ahmed SS; Kousar R; Ahmad T; Abid SMA; Ashfaq M; Khan SA
Curr Med Res Opin; 2022 Apr; 38(4):595-605. PubMed ID: 35166143
[TBL] [Abstract][Full Text] [Related]
4. Awareness, knowledge, attitude and practice of adverse drug reaction reporting among health workers and patients in selected primary healthcare centres in Ibadan, southwestern Nigeria.
Adisa R; Omitogun TI
BMC Health Serv Res; 2019 Dec; 19(1):926. PubMed ID: 31796034
[TBL] [Abstract][Full Text] [Related]
5. Healthcare professionals' knowledge, attitude and practice towards adverse drug reaction (ADR) reporting at the health center level in Ethiopia.
Seid MA; Kasahun AE; Mante BM; Gebremariam SN
Int J Clin Pharm; 2018 Aug; 40(4):895-902. PubMed ID: 30094559
[TBL] [Abstract][Full Text] [Related]
6. Exploring healthcare professionals' knowledge, attitude, and practices towards pharmacovigilance: a cross-sectional survey.
Hussain R; Hassali MA; Hashmi F; Akram T
J Pharm Policy Pract; 2021 Jan; 14(1):5. PubMed ID: 33397478
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of health care professionals' knowledge, attitudes, practices and barriers to pharmacovigilance and adverse drug reaction reporting: A cross-sectional multicentral study.
Khan Z; Karatas Y; Hamid SM
PLoS One; 2023; 18(5):e0285811. PubMed ID: 37224133
[TBL] [Abstract][Full Text] [Related]
8. Community pharmacists' knowledge and perspectives of reporting adverse drug reactions in Australia: a cross-sectional survey.
Li R; Curtain C; Bereznicki L; Zaidi STR
Int J Clin Pharm; 2018 Aug; 40(4):878-889. PubMed ID: 30097819
[TBL] [Abstract][Full Text] [Related]
9. Medication safety knowledge, attitudes and practices among community pharmacists in Lebanon.
Hajj A; Hallit S; Ramia E; Salameh P;
Curr Med Res Opin; 2018 Jan; 34(1):149-156. PubMed ID: 28758813
[TBL] [Abstract][Full Text] [Related]
10. Community pharmacists' challenges regarding adverse drug reaction reporting: a cross-sectional study.
Paut Kusturica M; Tomas A; Rašković A; Gigov S; Crnobrnja V; Jevtić M; Stilinović N
Curr Med Res Opin; 2022 Jul; 38(7):1229-1236. PubMed ID: 35470747
[TBL] [Abstract][Full Text] [Related]
11. Adverse Drug Reaction Monitoring and Reporting Among Physicians and Pharmacists in Pakistan: A Cross-sectional Study.
Nisa ZU; Zafar A; Zafar F; Pezaro S; Sher F
Curr Drug Saf; 2020; 15(2):137-146. PubMed ID: 32338223
[TBL] [Abstract][Full Text] [Related]
12. Knowledge, attitude and practice of physicians and nurses at the cape coast teaching hospital in the Central Region of Ghana on spontaneous adverse drug reaction reporting.
Powell JF; Henneh IT; Ekor M
PLoS One; 2023; 18(7):e0288100. PubMed ID: 37418384
[TBL] [Abstract][Full Text] [Related]
13. Under-reporting of adverse drug reactions: a challenge for pharmacovigilance in India.
Tandon VR; Mahajan V; Khajuria V; Gillani Z
Indian J Pharmacol; 2015; 47(1):65-71. PubMed ID: 25821314
[TBL] [Abstract][Full Text] [Related]
14. Exploring the knowledge, perception, and practice of community pharmacists in Saudi Arabia toward pharmacovigilance and adverse drug reaction reporting. A nationwide survey.
Khardali A
Sci Rep; 2024 Feb; 14(1):4819. PubMed ID: 38413787
[TBL] [Abstract][Full Text] [Related]
15. Safety of medicines-Pharmacists' knowledge, practice, and attitudes toward pharmacovigilance and adverse drug reactions reporting process.
Kopciuch D; Zaprutko T; Paczkowska A; Ratajczak P; Zielińska-Tomczak Ł; Kus K; Nowakowska E
Pharmacoepidemiol Drug Saf; 2019 Dec; 28(12):1543-1551. PubMed ID: 31148344
[TBL] [Abstract][Full Text] [Related]
16. Knowledge and attitude of health-care professionals in hospitals towards pharmacovigilance in Saudi Arabia.
Alshammari TM; Alamri KK; Ghawa YA; Alohali NF; Abualkol SA; Aljadhey HS
Int J Clin Pharm; 2015 Dec; 37(6):1104-10. PubMed ID: 26216270
[TBL] [Abstract][Full Text] [Related]
17. Detection and Reporting of Adverse Drug Reactions Related to Antibiotics in Primary Healthcare in Greece.
Geitona M; Toska A; Latsou D; Saridi M
Curr Drug Saf; 2022; 17(3):217-224. PubMed ID: 34749626
[TBL] [Abstract][Full Text] [Related]
18. Factors that facilitate reporting of adverse drug reactions by pharmacists in Saudi Arabia.
Aldryhim AY; Alomair A; Alqhtani M; Mahmoud MA; Alshammari TM; Pont LG; Kamal KM; Aljadhey H; Mekonnen AB; Alwhaibi M; Balkhi B; Alhawassi TM
Expert Opin Drug Saf; 2019 Aug; 18(8):745-752. PubMed ID: 31232612
[No Abstract] [Full Text] [Related]
19. Knowledge, attitude, practice and barriers towards pharmacovigilance and adverse drug reactions reporting among healthcare professionals in Turkey: a systematic review.
Khan Z; Karatas Y; Martins MAP; Jamshed S; Rahman H
Curr Med Res Opin; 2022 Jan; 38(1):145-154. PubMed ID: 34694167
[TBL] [Abstract][Full Text] [Related]
20. Barriers and facilitators to pharmacovigilance activities in Pakistan: A healthcare professionals-based survey.
Hussain R; Akram T; Hassali MA; Muneswarao J; Rehman AU; Hashmi F; Babar ZU
PLoS One; 2022; 17(7):e0271587. PubMed ID: 35905133
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]